|
1
|
Ferlay J, Bray F, Pisani P and Parkin DM:
GLOBOCAN 2000: Cancer incidence, mortality and prevalence
worldwide, version 1.0. IARC CancerBase No. 5. Lyon. (IARCPress).
2001.
|
|
2
|
Ramroth H, Dietz A and Becher H:
Interaction effects and population-attributable risks for smoking
and alcohol on laryngeal cancer and its subsites. A case-control
study from Germany. Methods Inf Med. 43:499–504. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shangina O, Brennan P, Szeszenia-Dabrowska
N, Mates D, Fabiánová E, Fletcher T, t'Mannetje A, Boffetta P and
Zaridze D: Occupational exposure and laryngeal and hypopharyngeal
cancer risk in central and eastern Europe. Am J Epidemiol.
164:367–375. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Talamini R, Bosetti C, La Vecchia C, Dal
Maso L, Levi F, Bidoli E, Negri E, Pasche C, Vaccarella S, Barzan
L, et al: Combined effect of tobacco and alcohol on laryngeal
cancer risk: a case-control study. Cancer Causes Control.
13:957–964. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Becher H, Ramroth H, Ahrens W, Risch A,
Schmezer P and Dietz A: Occupation, exposure to polycyclic aromatic
hydrocarbons and laryngeal cancer risk. Int J Cancer. 116:451–457.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ramroth H, Dietz A, Ahrens W and Becher H:
Occupational wood dust exposure and the risk of laryngeal cancer: a
population based case-control study in Germany. Am J Ind Med.
51:648–655. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nachalon Y, Cohen O, Alkan U, Shvero J and
Popovtzer A: Characteristics and outcome of laryngeal squamous cell
carcinoma in young adults. Oncol Lett. 13:1393–1397. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Scoumanne A and Chen X: The epithelial
cell transforming sequence 2, a guanine nucleotide exchange factor
for Rho GTPases, is repressed by p53 via protein methyltransferases
and is required for G1-S transition. Cancer Res. 66:6271–6279.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miki T, Smith CL, Long JE, Eva A and
Fleming TP: Oncogene ect2 is related to regulators of small
GTP-binding proteins. Nature. 362:462–465. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yüce O, Piekny A and Glotzer M: An
ECT2-centralspindlin complex regulates the localization and
function of RhoA. J Cell Biol. 170:571–582. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tatsumoto T, Xie X, Blumenthal R, Okamoto
I and Miki T: Human ECT2 is an exchange factor for Rho GTPases,
phosphorylated in G2/M phases, and involved in cytokinesis. J Cell
Biol. 147:921–928. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sano M, Genkai N, Yajima N, Tsuchiya N,
Homma J, Tanaka R, Miki T and Yamanaka R: Expression level of ECT2
proto-oncogene correlates with prognosis in glioma patients. Oncol
Rep. 16:1093–1098. 2006.PubMed/NCBI
|
|
13
|
Saito S, Liu XF, Kamijo K, Raziuddin R,
Tatsumoto T, Okamoto I, Chen X, Lee CC, Lorenzi MV, Ohara N, et al:
Deregulation and mislocalization of the cytokinesis regulator ECT2
activate the Rho signaling pathways leading to malignant
transformation. J Biol Chem. 279:7169–7179. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matthews HK, Delabre U, Rohn JL, Guck J,
Kunda P and Baum B: Changes in Ect2 localization couple
actomyosin-dependent cell shape changes to mitotic progression. Dev
Cell. 23:371–383. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luo Y, Qin SL, Mu YF, Wang ZS, Zhong M and
Bian ZQ: Elevated expression of ECT2 predicts unfavorable prognosis
in patients with colorectal cancer. Biomed Pharmacother.
73:135–139. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Murata Y, Minami Y, Iwakawa R, Yokota J,
Usui S, Tsuta K, Shiraishi K, Sakashita S, Satomi K, Iijima T, et
al: ECT2 amplification and overexpression as a new prognostic
biomarker for early-stage lung adenocarcinoma. Cancer Sci.
105:490–497. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Patel SG and Shah JP: TNM staging of
cancers of the head and neck: Striving for uniformity among
diversity. CA Cancer J Clin. 55:242–258; quiz 261–262, 264. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang HB, Yan HC and Liu Y: Clinical
significance of ECT2 expression in tissue and serum of gastric
cancer patients. Clin Transl Oncol. 18:735–742. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo Z, Chen X, Du T, Zhu D, Lai Y, Dong W,
Wu W, Lin C, Liu L and Huang H: Elevated levels of epithelial cell
transforming sequence 2 predicts poor prognosis for prostate
cancer. Med Oncol. 34:132017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rizzardi AE, Johnson AT, Vogel RI,
Pambuccian SE, Henriksen J, Skubitz AP, Metzger GJ and Schmechel
SC: Quantitative comparison of immunohistochemical staining
measured by digital image analysis versus pathologist visual
scoring. Diagn Pathol. 7:422012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOCAN 2012 v1.0, Cancer incidence and mortality
worldwide: IARC CancerBase No. 11. International Agency for
Research on Cancer. (Lyon, France). 2013.
|
|
23
|
Justilien V, Jameison L, Der CJ, Rossman
KL and Fields AP: Oncogenic activity of Ect2 is regulated through
protein kinase C iota-mediated phosphorylation. J Biol Chem.
286:8149–8157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Justilien V and Fields AP: Ect2 links the
PKCiota-Par6alpha complex to Rac1 activation and cellular
transformation. Oncogene. 28:3597–3607. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vergote I, De Brabanter J, Fyles A,
Bertelsen K, Einhorn N, Sevelda P, Gore ME, Kaern J, Verrelst H,
Sjövall K, et al: Prognostic importance of degree of
differentiation and cyst rupture in stage I invasive epithelial
ovarian carcinoma. Lancet. 357:176–182. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ostergaard M, Rasmussen HH, Nielsen HV,
Vorum H, Orntoft TF, Wolf H and Celis JE: Proteome profiling of
bladder squamous cell carcinomas: Identification of markers that
define their degree of differentiation. Cancer Res. 57:4111–4117.
1997.PubMed/NCBI
|
|
27
|
Pollina L, Pacini F, Fontanini G, Vignati
S, Bevilacqua G and Basolo F: bcl-2, p53 and proliferating cell
nuclear antigen expression is related to the degree of
differentiation in thyroid carcinomas. Br J Cancer. 73:139–143.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Elston CW and Ellis IO: Pathological
prognostic factors in breast cancer. I. The value of histological
grade in breast cancer: Experience from a large study with
long-term follow-up. Histopathology. 19:403–410. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cook DR, Rossman KL and Der CJ: Rho
guanine nucleotide exchange factors: Regulators of Rho GTPase
activity in development and disease. Oncogene. 33:4021–4035. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mack NA and Georgiou M: The
interdependence of the Rho GTPases and apicobasal cell polarity.
Small GTPases. 5:102014. View Article : Google Scholar : PubMed/NCBI
|
